{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T00:17:37Z","timestamp":1792282657987,"version":"4.4.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ministry of Health, Labor, and Welfare of Japan","award":["7244000214"],"award-info":[{"award-number":["7244000214"]}]},{"name":"Japanese Agency for Medical Research and Development","award":["PJ44270005"],"award-info":[{"award-number":["PJ44270005"]}]},{"name":"Grant-in-Aid for Young Scientists","award":["15K20831"],"award-info":[{"award-number":["15K20831"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.jconrel.2017.09.044","type":"journal-article","created":{"date-parts":[[2017,10,3]],"date-time":"2017-10-03T08:15:59Z","timestamp":1507018559000},"page":"216-225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":106,"special_numbering":"C","title":["Highly specific delivery of siRNA to hepatocytes circumvents endothelial cell-mediated lipid nanoparticle-associated toxicity leading to the safe and efficacious decrease in the hepatitis B virus"],"prefix":"10.1016","volume":"266","author":[{"given":"Yusuke","family":"Sato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risa","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsubasa","family":"Munakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michinori","family":"Kohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1568-9547","authenticated-orcid":false,"given":"Hideyoshi","family":"Harashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2017.09.044_bb0005","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nrg3978","article-title":"Knocking down disease: a progress report on siRNA therapeutics","volume":"16","author":"Wittrup","year":"2015","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jconrel.2017.09.044_bb0010","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nmat3765","article-title":"Delivery materials for siRNA therapeutics","volume":"12","author":"Kanasty","year":"2013","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2017.09.044_bb0015","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/gt.2008.60","article-title":"The size of endothelial fenestrae in human liver sinusoids: implications for hepatocyte-directed gene transfer","volume":"15","author":"Wisse","year":"2008","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2017.09.044_bb0020","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2353\/ajpath.2010.090136","article-title":"The role of liver sinusoidal cells in hepatocyte-directed gene transfer","volume":"176","author":"Jacobs","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jconrel.2017.09.044_bb0025","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bbrc.2004.12.137","article-title":"The role of apolipoprotein E in the elimination of liposomes from blood by hepatocytes in the mouse","volume":"328","author":"Yan","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2017.09.044_bb0030","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/mt.2010.85","article-title":"Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms","volume":"18","author":"Akinc","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2017.09.044_bb0035","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jconrel.2015.02.022","article-title":"Asialoglycoprotein receptor mediated hepatocyte targeting - strategies and applications","volume":"203","author":"D'Souza","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.09.044_bb0040","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nbt.1602","article-title":"Rational design of cationic lipids for siRNA delivery","volume":"28","author":"Semple","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2017.09.044_bb0045","doi-asserted-by":"crossref","first-page":"8529","DOI":"10.1002\/anie.201203263","article-title":"Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo","volume":"51","author":"Jayaraman","year":"2012","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2017.09.044_bb0050","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nbt1402","article-title":"A combinatorial library of lipid-like materials for delivery of RNAi therapeutics","volume":"26","author":"Akinc","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2017.09.044_bb0055","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1073\/pnas.0910603106","article-title":"Lipid-like materials for low-dose, in vivo gene silencing","volume":"107","author":"Love","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2017.09.044_bb0060","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jconrel.2012.09.009","article-title":"cationic lipid facilitates the delivery of liposomal siRNA and gene silencing activity in vitro and in vivo","volume":"163","author":"Sato","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.09.044_bb0065","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jhep.2015.10.014","article-title":"Novel pH-sensitive multifunctional envelope-type nanodevice for siRNA-based treatments for chronic HBV infection","volume":"64","author":"Yamamoto","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2017.09.044_bb0070","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/mt.2015.222","article-title":"Relationship between the physicochemical properties of lipid nanoparticles and the quality of siRNA delivery to liver cells","volume":"24","author":"Sato","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2017.09.044_bb0075","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/mt.2009.208","article-title":"Evaluation of efficacy, biodistribution, and inflammation for a potent siRNA nanoparticle: effect of dexamethasone co-treatment","volume":"18","author":"Abrams","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2017.09.044_bb0080","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/j.addr.2012.06.007","article-title":"Safety profile of RNAi nanomedicines","volume":"64","author":"Barros","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.09.044_bb0085","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.antiviral.2013.01.006","article-title":"Chronic hepatitis B: what should be the goal for new therapies?","volume":"98","author":"Block","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jconrel.2017.09.044_bb0090","article-title":"Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections","author":"Rehermann","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2017.09.044_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coviro.2014.04.005","article-title":"Nucleoside\/nucleotide analog inhibitors of hepatitis B virus polymerase: mechanism of action and resistance","volume":"8c","author":"Menendez-Arias","year":"2014","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.jconrel.2017.09.044_bb0100","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/jmv.10566","article-title":"Virological significance of low-level hepatitis B virus infection in patients with hepatitis C virus associated liver disease","volume":"72","author":"Tanaka","year":"2004","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jconrel.2017.09.044_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071057","article-title":"A human in vitro whole blood assay to predict the systemic cytokine response to therapeutic oligonucleotides including siRNA","volume":"8","author":"Coch","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2017.09.044_bb0110","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1172\/JCI37515","article-title":"Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice","volume":"119","author":"Judge","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2017.09.044_bb0115","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ijpharm.2015.08.044","article-title":"Size-dependent specific targeting and efficient gene silencing in peritoneal macrophages using a pH-sensitive cationic liposomal siRNA carrier","volume":"495","author":"Matsui","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.044_bb0120","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jconrel.2016.03.019","article-title":"Elucidation of the physicochemical properties and potency of siRNA-loaded small-sized lipid nanoparticles for siRNA delivery","volume":"229","author":"Sato","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.09.044_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2613.2003.00235.x","article-title":"Role of cell adhesion molecules in leukocyte recruitment in the liver and gut","volume":"84","author":"Ala","year":"2003","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.jconrel.2017.09.044_bb0130","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ijpharm.2007.06.012","article-title":"Innate immune response induced by gene delivery vectors","volume":"354","author":"Sakurai","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.044_bb0135","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/hep.27841","article-title":"Damage-associated molecular pattern-activated neutrophil extracellular trap exacerbates sterile inflammatory liver injury","volume":"62","author":"Huang","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2017.09.044_bb0140","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2337\/db09-0016","article-title":"Depletion of liver Kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance","volume":"59","author":"Huang","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.jconrel.2017.09.044_bb0145","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0022-1759(94)90012-4","article-title":"Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications","volume":"174","author":"Van Rooijen","year":"1994","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jconrel.2017.09.044_bb0150","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1365-2893.1999.00174.x","article-title":"Does hepatitis B virus (HBV) genotype influence the clinical outcome of HBV infection?","volume":"6","author":"Mayerat","year":"1999","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.jconrel.2017.09.044_bb0155","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1189\/jlb.0405181","article-title":"Cationic liposomes induce apoptosis through p38 MAP kinase-caspase-8-Bid pathway in macrophage-like RAW264.7 cells","volume":"79","author":"Iwaoka","year":"2006","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jconrel.2017.09.044_bb0160","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1016\/j.molimm.2007.04.009","article-title":"Mechanism of adjuvant activity of cationic liposome: phosphorylation of a MAP kinase, ERK and induction of chemokines","volume":"44","author":"Yan","year":"2007","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jconrel.2017.09.044_bb0165","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1124\/jpet.107.136077","article-title":"Dependence of reactive oxygen species and FLICE inhibitory protein on lipofectamine-induced apoptosis in human lung epithelial cells","volume":"325","author":"Kongkaneramit","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2017.09.044_bb0170","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jconrel.2010.07.114","article-title":"Didodecyldimethylammonium bromide (DDAB) induces caspase-mediated apoptosis in human leukemia HL-60 cells","volume":"147","author":"Kusumoto","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.09.044_bb0175","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1006\/abbi.2001.2458","article-title":"Cationic liposomes induce macrophage apoptosis through mitochondrial pathway","volume":"392","author":"Aramaki","year":"2001","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jconrel.2017.09.044_bb0180","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0005-2736(00)00343-6","article-title":"Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures","volume":"1510","author":"Semple","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2017.09.044_bb0185","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jconrel.2005.06.014","article-title":"Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids","volume":"107","author":"Heyes","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.09.044_bb0190","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/mt.2010.282","article-title":"Mechanistically probing lipid-siRNA nanoparticle-associated toxicities identifies Jak inhibitors effective in mitigating multifaceted toxic responses","volume":"19","author":"Tao","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2017.09.044_bb0195","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2014.61","article-title":"Shielding of lipid nanoparticles for siRNA delivery: impact on physicochemical properties, cytokine induction, and efficacy","volume":"3","author":"Kumar","year":"2014","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.jconrel.2017.09.044_bb0200","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1016\/S0006-3495(03)74986-8","article-title":"Mechanism of pH-triggered collapse of phosphatidylethanolamine liposomes stabilized by an ortho ester polyethyleneglycol lipid","volume":"84","author":"Guo","year":"2003","journal-title":"Biophys. J."},{"key":"10.1016\/j.jconrel.2017.09.044_bb0205","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nm.2184","article-title":"Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases","volume":"16","author":"Massberg","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2017.09.044_bb0210","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.cbi.2015.04.011","article-title":"The impact of cationic solid lipid nanoparticles on human neutrophil activation and formation of neutrophil extracellular traps (NETs)","volume":"235","author":"Hwang","year":"2015","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.jconrel.2017.09.044_bb0215","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s004410100348","article-title":"Fluid phase endocytosis of [125I]iodixanol in rat liver parenchymal, endothelial and Kupffer cells","volume":"304","author":"Kjeken","year":"2001","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.jconrel.2017.09.044_bb0220","doi-asserted-by":"crossref","first-page":"4230","DOI":"10.1016\/S0021-9258(18)34710-0","article-title":"Kinetics of internalization and recycling of the asialoglycoprotein receptor in a hepatoma cell line","volume":"257","author":"Schwartz","year":"1982","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2017.09.044_bb0225","doi-asserted-by":"crossref","first-page":"5798","DOI":"10.1021\/jm049481d","article-title":"Design and synthesis of novel N-acetylgalactosamine-terminated glycolipids for targeting of lipoproteins to the hepatic asialoglycoprotein receptor","volume":"47","author":"Rensen","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2017.09.044_bb0230","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1248\/bpb.b13-00059","article-title":"The polyethyleneglycol dilemma: advantage and disadvantage of PEGylation of liposomes for systemic genes and nucleic acids delivery to tumors","volume":"36","author":"Hatakeyama","year":"2013","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jconrel.2017.09.044_bb0235","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fphar.2015.00286","article-title":"Advances and challenges of liposome assisted drug delivery","volume":"6","author":"Sercombe","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2017.09.044_bb0240","doi-asserted-by":"crossref","first-page":"428169","DOI":"10.1155\/2015\/428169","article-title":"Adverse events of monoclonal antibodies used for cancer therapy","volume":"2015","author":"Guan","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.jconrel.2017.09.044_bb0245","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/mt.2013.124","article-title":"Biodegradable lipids enabling rapidly eliminated lipid nanoparticles for systemic delivery of RNAi therapeutics","volume":"21","author":"Maier","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2017.09.044_bb0250","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.abb.2011.12.009","article-title":"Involvement of actin cytoskeleton in macrophage apoptosis induced by cationic liposomes","volume":"518","author":"Takano","year":"2012","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jconrel.2017.09.044_bb0255","doi-asserted-by":"crossref","first-page":"18440","DOI":"10.1021\/jp303267y","article-title":"Lipid nanoparticles containing siRNA synthesized by microfluidic mixing exhibit an electron-dense nanostructured core","volume":"116","author":"Leung","year":"2012","journal-title":"J. Phys. Chem. C Nanomater. Interfaces"},{"key":"10.1016\/j.jconrel.2017.09.044_bb0260","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1074-7613(00)80295-2","article-title":"Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes","volume":"4","author":"Guidotti","year":"1996","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2017.09.044_bb0265","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1126\/science.284.5415.825","article-title":"Viral clearance without destruction of infected cells during acute HBV infection","volume":"284","author":"Guidotti","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2017.09.044_bb0270","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1128\/JVI.76.7.3570-3574.2002","article-title":"Inhibition of hepatitis B virus replication by interferon requires proteasome activity","volume":"76","author":"Robek","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2017.09.044_bb0275","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1053\/j.gastro.2015.09.026","article-title":"Interferon-\u03b3 and tumor necrosis factor-\u03b1 produced by T cells reduce the HBV persistence form, cccDNA, without cytolysis","volume":"150","author":"Xia","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jconrel.2017.09.044_bb0280","doi-asserted-by":"crossref","first-page":"8609","DOI":"10.1128\/JVI.76.17.8609-8620.2002","article-title":"Immunogenicity and tolerogenicity of hepatitis B virus structural and nonstructural proteins: implications for immunotherapy of persistent viral infections","volume":"76","author":"Kakimi","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2017.09.044_bb0285","doi-asserted-by":"crossref","first-page":"14913","DOI":"10.1073\/pnas.0406282101","article-title":"A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen","volume":"101","author":"Chen","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2017.09.044_bb0290","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1053\/j.gastro.2012.02.007","article-title":"High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load","volume":"142","author":"Tseng","year":"2012","journal-title":"Gastroenterology"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917308878?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917308878?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T21:45:35Z","timestamp":1659563135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365917308878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":58,"alternative-id":["S0168365917308878"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.09.044","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Highly specific delivery of siRNA to hepatocytes circumvents endothelial cell-mediated lipid nanoparticle-associated toxicity leading to the safe and efficacious decrease in the hepatitis B virus","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.09.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}